Drug Trial Radar · NCT06980480
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
183
Planned (sponsor's estimate)
Start
Jan 14, 2026
Primary completion
Sep 11, 2028
Study completion Sep 11, 2028
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- Collaborators
- Takeda Development Center Americas, Inc.; Baxalta Innovations GmbH, now part of Takeda
- First posted
- May 20, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Multiple myeloma is a cancer of the plasma cells in the bone marrow. The main aim of this study is to learn how well the Immune Globulin Infusion (human), 10 percentage (%) (IGI, 10%) can help prevent infections in participants with multiple myeloma receiving B-cell maturation antigen (BCMA) x cluster of differentiation 3 (CD3) directed bispecific antibody therapy. Participants will be randomly assigned to one of two groups: 1. Primary infection prevention group: They will receive IGI, 10% for 12 months. 2. Secondary infection prevention group: They will only receive IGI, 10% if they develop a serious infection during the 12 months study period. During the study, participants will visit their study clinic 15 times (for 4-week dosing interval) or 19 times (for 3-week dosing interval) and their total participation duration will be up to 14 months (including screening period approximately 8 weeks).
Conditions
- Multiple Myeloma
- Secondary Immunodeficiency
Interventions
IGI, 10%Biological
IGI, 10% IV infusion.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time To the First Serious InfectionTime frame: Up to 12 months
Locations
68 sites in 17 countries. Site status is shown where the registry gives one.
Infirmary Health - Diagnostic & Medical Clinic (DMC)
Mobile, Alabama · Recruiting
Chao Family Comprehensive Cancer Center UCI
Orange, California · Recruiting
University of Kansas
Westwood, Kansas · Recruiting
University of Maryland | Greenebaum Cancer Center
Baltimore, Maryland · Recruiting
Henry Ford Health System
Detroit, Michigan · Recruiting
Washington University School of Medicine
St Louis, Missouri · Recruiting
New York Oncology Hematology
Albany, New York · Recruiting
St Vincents Hospital Melbourne
Melbourne, Australia · Recruiting
St George Private Hospital
Kogarah, New South Wales, Australia · Recruiting
Townsville Hospital
Douglas, Queensland, Australia · Recruiting
Greenslopes Private Hospital
Greenslopes, Queensland, Australia · Recruiting
Royal Adelaide Hospital
Adelaide, South Australia, Australia · Recruiting
Freemasons Hospital, Epworth Health
East Melbourne, Victoria, Australia · Recruiting
Western Health - Sunshine Hospital
St Albans, Victoria, Australia · Recruiting
Fiona Stanley Hospital
Murdoch, Western Australia, Australia · Recruiting
A O Krankenhaus der Elisabethinen
Linz, Austria · Recruiting
Universitaetsklinikum St. Poelten
Sankt Pölten, Austria · Recruiting
Krankenhaus der Barmherzigen Schwestern Wien
Vienna, Austria · Recruiting
Sao Jose do Rio Preto Regional Faculty of Medicine FoundationSao Jose do Rio Preto Regional Faculty of Medicine Foundation
Porto Alegre, Brazil · Recruiting
Instituto Oncoclínicas de Ensino
Rio de Janeiro, Brazil · Recruiting
Instituto D'Or de Pesquisa e Ensino
Salvador, Brazil · Recruiting
Instituto D'Or de Pesquisa e Ensino - Sao Paulo
São Paulo, Brazil · Recruiting
Centro de Hematologia e Oncologia (CHO)
Joinville, Santa Catarina, Brazil · Recruiting
Cancer Care Manitoba
Winnipeg, Manitoba, Canada · Recruiting
Centre Hospitalier de l'Universite de Montreal
Montreal, Quebec, Canada · Recruiting
Fakultni Nemocnice Ostrava (FNO) - Neurologicke klinika
Ostrava, Czechia · Recruiting
Aalborg Hospital
Aalborg, Denmark · Recruiting
Aarhus Universitetshospital
Aarhus, Denmark · Recruiting
Copenhagen University Hospital
Copenhagen, Denmark · Recruiting
Odense Universitetshospital
Odense, Denmark · Recruiting
Alexandra General Hospital of Athens
Athens, Greece · Recruiting
University General Hospital of Ioannina
Ioannina, Greece · Recruiting
University of Debrecen DEOEC
Debrecen, Hungary · Recruiting
Somogy Megyei Kaposi Mor Oktato Korhaz
Kaposvár, Hungary · Recruiting
Markusovszky Egyetemi Oktatokorhaz
Szombathely, Hungary · Recruiting
Shaare Zedek Medical Center
Jerusalem, Israel · Recruiting
Sheba Medical Center
Ramat Gan, Israel · Recruiting
Azienda Ospedaliero Universitaria Policlinico G. Rodolico San Marco
Catania, Italy · Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Pavia, Italy · Recruiting
Azienda Sanitaria Locale di Pescara Ospedale Civile Dello Spirito Santo
Pescara, Italy · Recruiting
Showing 40 of 68 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.